MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hs9.0000000000000926

Медицинская библиотека · HemaSphere · 2023

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.

Treiber Hannes, Nilius-Eliliwi Verena, Seifert Nicole, Vangala Deepak, Wang Meng, Seidel Sabine, Mika Thomas, Marschner Dominik, Zeremski Vanja, Wurm-Kuczera Rebecca, Caillé Leandra, Chapuy Claudia I, Trümper Lorenz, Fischer Thomas, Altenbuchinger Michael, Wulf Gerald G, Illerhaus Gerald, Dietrich Sascha, Schroers Roland, Chapuy Björn

СтатьяПеревод пока не подготовлен

Аннотация

Secondary central nervous system lymphoma (SCNSL) is a rare and difficult to treat type of Non-Hodgkin lymphoma characterized by systemic and central nervous system (CNS) disease manifestations. In this study, 124 patients with SCNSL intensively treated and with clinical long-term follow-up were included. Initial histopathology, as divided in low-grade, other aggressive, and diffuse large B-cell lymphoma (DLBCL), was of prognostic significance. Overall response to induction treatment was a prognostic factor with early responding DLBCL-SCNSL in comparison to those non-responding experiencing a significantly better progression-free survival (PFS) and overall survival (OS). However, the type of induction regime was not prognostic for survival. Following consolidating high-dose chemotherapy and autologous stem cell transplantation (HDT-ASCT), DLBCL-SCNSL patients had better median PFS and OS. The important role of HDT-ASCT was further highlighted by favorable responses and survival of patients not responding to induction therapy and by excellent results in patients with de novo DLBCL-SCNSL (65% long-term survival). SCNSL identified as a progression of disease within 6 months of initial systemic lymphoma presentation represented a previously not appreciated subgroup with particularly dismal outcome. This temporal stratification model of SCNSL diagnosis revealed CNS progression of disease within 6 months as a promising candidate prognosticator for future studies.

Для цитирования: Treiber Hannes, Nilius-Eliliwi Verena, Seifert Nicole, Vangala Deepak, Wang Meng, Seidel Sabine, Mika Thomas, Marschner Dominik, Zeremski Vanja, Wurm-Kuczera Rebecca, Caillé Leandra, Chapuy Claudia I, Trümper Lorenz, Fischer Thomas, Altenbuchinger Michael, Wulf Gerald G, Illerhaus Gerald, Dietrich Sascha, Schroers Roland, Chapuy Björn. Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.. HemaSphere. 2023. DOI: 10.1097/hs9.0000000000000926.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.